Pentavac Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilus influenzae type b co Ireland - English - HPRA (Health Products Regulatory Authority)

pentavac diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and haemophilus influenzae type b co

sanofi pasteur - purified diphtheria toxoid ph. eur.; purified tetanus toxoid; adsorbed purified pertussis toxoid; adsorbed purified filamentous haemagglutinin; inactivated poliomyelitis virus ph. eur; inactivated type 1 poliovirus; inactivated type 2 poliovirus; inactivated type 3 poliovirus; haemophilus influenzae type b, conjugate with tetanus protein - powder for suspension for injection - 0.5 millilitre(s) - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

PENTAVAC 0 %v/v Powder for suspension for injection Ireland - English - HPRA (Health Products Regulatory Authority)

pentavac 0 %v/v powder for suspension for injection

sanofi pasteur msd ltd - purified diphtheria toxoid ph. eur., purified tetanus toxoid, adsorbed purified pertussis toxoid, adsorbed purified filamentous haemagglutinin, inactivated poliomyelitis virus ph. eur, inactivated type 1 poliovirus, inactivated type 2 poliovirus, inactivated type 3 poliovirus, haemophilus influenzae type b, conjugate with tetanus protein - powder for suspension for injection - 0 %v/v - bacterial and viral vaccines, combined

Pentavac Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pentavac

sm pharmaceuticals sdn. bhd. - diphtheria toxoid; haemophilus influenza type b conjugate; hepatitis b, purified antigen; tetanus toxoid; bulk pertussis vaccine -

PENTAVAC HIBRO & Q-VAC AMP VACC India - English - Central Drugs Standard Control Organization

pentavac hibro & q-vac amp vacc

serum inst. - diphtheria pertusis and tetanus & hib - vacc - hibro & q-vac amp

Pentavac inj. susp. (pwdr. + susp.) i.m. vial + pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pentavac inj. susp. (pwdr. + susp.) i.m. vial + pre-filled syr.

sanofi pasteur europe s.a. - poliovirus type 1 (inactivated) 40 d-antigen u/1 dose; bordetella pertussis toxoid (pt) 25 µg/dose; conjugate of haemophilus influenzae type b capsular polysaccharide and tetanus toxoid 10 µg/dose; bordetella pertussis filamentous hemagglutinin (fha) 25 µg/dose; tetanus toxoid >= 40 iu/dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; diphtheria toxoid (dt) >= 30 iu/dose; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose - powder and suspension for suspension for injection - diphteria antigen, adsorbed; haemophilus influenzae type b polysaccharides, conjugated to tetanus toxoid; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus